Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LymBIO: Lymph Node Microenvironment in CLL
NCT04790045Phase 4Not yet recruiting
- Start
- Nov 2023
- Primary completion
- Dec 2026
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of venetoclax in chronic lymphocytic leukemia (CLL). Planned start Nov 2023; status: not yet recruiting.
02
Drugs
venetoclax
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT04790045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04790045.